GO:0030870 Mre11 complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0030870 (Mre11 complex) is a trimeric cellular component with endonuclease activity, conserved from yeast (Mre11p-Rad50p-Xrs2p) to humans (MRE11-RAD50-NBS1, MRN).
• The complex is a central sensor and effector of DNA double-strand break repair, meiotic recombination, and checkpoint signaling.
• Its dynamic ATP-dependent conformational changes allow DNA tethering, end processing, and activation of ATM-dependent signaling.
• Mutations in MRE11, RAD50, and NBS1 cause cancer predisposition and rare genomic instability syndromes, making the complex a therapeutic target.
• CRISPR knockout, point-mutation knock-in, and tagged knock-in models are essential to dissect subunit-specific functions and disease variants.
• Understanding Mre11 complex biology informs cancer prognosis, DNA-damage-response inhibitor development, and synthetic lethality strategies.
Description
The Mre11 complex (GO:0030870) is a conserved, trimeric protein machine that serves as a primary sensor and processor of DNA double-strand breaks (DSBs). In Saccharomyces cerevisiae, the complex comprises Mre11p, Rad50p, and Xrs2p, while its human counterpart, known as MRN, consists of MRE11, RAD50, and NBS1 (NBN). This complex is essential for homologous recombination, non-homologous end joining, meiotic recombination, and DNA damage checkpoint signaling, placing it at the heart of genome maintenance. Researchers study GO:0030870 to understand fundamental DNA repair mechanisms and to exploit its dysfunction in cancer and inherited genomic instability disorders. The Mre11 complex is not a static entity; it undergoes dynamic, ATP-dependent conformational changes that regulate its endonuclease and exonuclease activities, as well as its ability to tether broken DNA ends. These properties make it a paradigm for understanding how molecular machines coordinate DNA processing with signaling. Given its clinical relevance, the Mre11 complex is a prime target for CRISPR-based disease modeling and therapeutic development.
Mre11 complex At A Glance
| GO ID | GO:0030870 |
|---|---|
| GO term | Mre11 complex |
| Ontology | cellular_component |
| Synonym | MRN complex, MRX complex, Rad50 complex, RAD50-MRE11-NBN complex, Rad50-Rad32-Nbs1 complex, RMX complex |
| Major function | Endonuclease activity; meiotic recombination; DNA repair; checkpoint signaling |
| Yeast subunits | Mre11p, Rad50p, Xrs2p |
| Human subunits | MRE11, RAD50, NBS1 (NBN) |
| Conservation | Conserved from yeast to humans; orthologous complexes in other species |
| Associated activity | ATP-dependent DNA tethering and end processing |
What Is GO:0030870?
The Mre11 complex is a trimeric protein complex that possesses endonuclease activity and is involved in meiotic recombination, DNA repair, and checkpoint signaling. In Saccharomyces cerevisiae, the complex is composed of Mre11p, Rad50p, and Xrs2p; in other species, the complex generally contains orthologs of these proteins, such as the human MRE11-RAD50-NBS1 (MRN) complex. The complex functions as a structural and enzymatic hub that recognizes DNA breaks, processes DNA ends, and initiates signaling cascades to halt the cell cycle until damage is repaired.
Why Is Mre11 complex Important in Cell Biology?
The Mre11 complex is critically important because it orchestrates the earliest steps of DNA double-strand break repair and checkpoint activation, processes that are fundamental to genome stability and cancer avoidance. Dysregulation or mutation of its components leads to genomic instability, cancer predisposition, and rare inherited disorders, making it a key focus for both basic research and clinical translation.
• Central sensor of DNA double-strand breaks and initiator of repair.
• Essential for homologous recombination and meiotic recombination.
• Required for ATM-dependent DNA damage checkpoint signaling.
• Mutations in MRE11, RAD50, and NBS1 cause cancer predisposition syndromes.
• Altered expression correlates with prognosis in colorectal and other cancers.
• Target for cancer therapy via synthetic lethality and DNA repair inhibitors.
• Dynamic conformational changes regulate its enzymatic and tethering functions.
• Model organism studies (S. cerevisiae) reveal conserved mechanisms.
• Involved in processing of blocked DNA ends and resection.
• Potential biomarker for DNA-damaging agent response.
Structure and Composition of Mre11 complex
Trimeric Core Assembly
In simple terms: The Mre11 complex is built from three proteins that fit together like a molecular machine.
The Mre11 complex is a heterotrimer. In Saccharomyces cerevisiae, it consists of Mre11p, Rad50p, and Xrs2p; in humans, the orthologous subunits are MRE11, RAD50, and NBS1 (NBN). MRE11 provides the catalytic endonuclease and exonuclease activities, RAD50 contains ATPase domains and a long coiled-coil that mediates DNA tethering, and NBS1/Xrs2 serves as a regulatory and interaction hub that recruits the complex to damage sites and activates signaling.
RAD50 ATPase and Coiled-Coil Architecture
In simple terms: RAD50 acts like a molecular hook that can hold broken DNA ends together.
RAD50 belongs to the SMC-like family of ATPases and forms a dimer through its coiled-coil domains, creating a flexible arm that can tether DNA molecules. ATP binding and hydrolysis induce conformational changes that regulate the complex's activities, including endonuclease and exonuclease functions. Structural studies in S. cerevisiae have revealed how Rad50's ATPase cycle coordinates with Mre11's catalytic site.
MRE11 Catalytic Domain and DNA Binding
In simple terms: MRE11 is the cutting tool that trims DNA ends.
MRE11 contains a conserved nuclease domain that can cleave DNA endonucleolytically and exonucleolytically, and it also has a DNA-binding domain that recognizes broken ends. The catalytic activity of MRE11 is essential for processing DNA ends during repair, and its function is modulated by interactions with RAD50 and NBS1.
NBS1/Xrs2 Regulatory Subunit
In simple terms: NBS1 is the organizer that brings the complex to the right place and time.
NBS1 (or Xrs2 in yeast) contains interaction domains for MRE11, ATM, and other DNA damage response proteins. It is required for nuclear localization, for efficient ATM activation, and for the checkpoint response. Mutations in NBS1 cause Nijmegen breakage syndrome, highlighting its critical role.
Dynamic Conformational States
In simple terms: The complex changes shape to perform different tasks.
The Mre11 complex is highly dynamic, transitioning between open and closed conformations in an ATP-dependent manner. These conformational changes regulate DNA binding, end processing, and the activation of downstream signaling. Recent structural work in S. cerevisiae has provided mechanistic insights into how these states are coupled to function.
Key Genes Involved in GO:0030870 Mre11 complex
The Mre11 complex comprises several core and accessory proteins that are conserved across species and are critical for its assembly and function.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MRE11 (Mre11p) | Catalytic subunit with endonuclease/exonuclease activity; DNA binding | Mutations cause ataxia-telangiectasia-like disorder; target for cancer studies |
| RAD50 (Rad50p) | ATPase; DNA tethering; structural maintenance | Mutations linked to Nijmegen breakage syndrome-like disorder and cancer |
| NBS1 (NBN, Xrs2p) | Regulatory subunit; ATM activation; nuclear localization | Mutations cause Nijmegen breakage syndrome; prognostic marker in cancer |
| ATM | Kinase activated by MRN; checkpoint signaling | Defects cause ataxia-telangiectasia; MRN-ATM axis is a therapeutic target |
| CTIP (RBBP8) | End resection factor; interacts with MRN | Regulates repair pathway choice; cancer relevance |
| EXO1 | Exonuclease; promotes long-range resection | Cooperates with MRN in homologous recombination |
| BLM | Helicase; resolves recombination intermediates | Interacts with MRN; defects cause Bloom syndrome |
| BRCA1 | Tumor suppressor; promotes homologous recombination | Synthetic lethality with MRN defects |
| BRCA2 | Homologous recombination mediator | Interacts with RAD51; cancer predisposition |
| RAD51 | Recombinase; strand invasion | Downstream of MRN in HR; cancer target |
| TP53BP1 | DNA damage response factor; promotes NHEJ | Antagonizes BRCA1; affects MRN pathway choice |
| MDC1 | Mediator of DNA damage checkpoint | Recruits MRN to damage sites |
| H2AX | Histone variant; marks damage sites | Phosphorylated by ATM; MRN-dependent |
| UBE2I (UBC9) | SUMO-conjugating enzyme | May regulate MRN complex via SUMOylation |
| UFM1 | Ubiquitin-like modifier | MRE11 UFMylation promotes ATM activation |
| SIRT2 | Deacetylase | May regulate MRE11 acetylation and function |
| CDK1 | Cell cycle kinase | Phosphorylates MRN components to regulate activity |
| PLK1 | Polo-like kinase | Regulates MRN function in mitosis |
How Is Mre11 complex Regulated?
The Mre11 complex is regulated at multiple levels, including ATP binding and hydrolysis, post-translational modifications, and protein-protein interactions. ATP binding to RAD50 induces conformational changes that control MRE11's nuclease activity and DNA tethering. Phosphorylation by cell cycle kinases such as CDK1 and PLK1 modulates its activity during different cell cycle phases. UFMylation of MRE11 has been shown to promote ATM activation, linking ubiquitin-like modifications to checkpoint signaling. Additionally, SUMOylation and acetylation may influence complex assembly and function.
Mre11 complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NBS1 (NBN) | Nijmegen breakage syndrome; cancer predisposition | Knockout or point-mutation knock-in in cell lines; patient-derived iPSCs |
| MRE11 | Ataxia-telangiectasia-like disorder; cancer | Knockout and point-mutation models; mouse models |
| RAD50 | Nijmegen breakage syndrome-like disorder; cancer | Knockout and knock-in of patient mutations |
| MRE11 | Colorectal cancer prognosis | Knockout in colorectal cancer cell lines; xenografts |
| RAD50 | Breast cancer susceptibility | Knockout in breast epithelial cells; organoids |
Cancer Predisposition and Genomic Instability
Mutations in MRE11, RAD50, and NBS1 are associated with increased cancer risk, including breast, ovarian, and colorectal cancers. The MRN complex acts as a barrier to tumorigenesis by maintaining genome stability, and its loss leads to accumulation of DNA damage and chromosomal aberrations. In colorectal cancer, altered expression of MRN components has prognostic implications.
Nijmegen Breakage Syndrome and Ataxia-Telangiectasia-Like Disorder
Biallelic mutations in NBS1 cause Nijmegen breakage syndrome, characterized by microcephaly, immunodeficiency, and cancer predisposition. Hypomorphic mutations in MRE11 cause ataxia-telangiectasia-like disorder, with progressive cerebellar ataxia and radiosensitivity. These disorders underscore the non-redundant roles of MRN subunits in development and genome maintenance.
Therapeutic Targeting and Synthetic Lethality
Tumors with MRN defects may be sensitive to DNA-damaging agents or PARP inhibitors due to synthetic lethality. Targeting the MRN complex or its downstream effectors is an active area of cancer drug development. Understanding the specific mutations and their functional consequences is essential for precision medicine.
From Mre11 complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of MRE11 nuclease deficiency on DNA repair? | MRE11 knockout or nuclease-dead point mutant (e.g., H129N) cell lines |
| How do patient-derived NBS1 mutations affect ATM activation? | NBS1 knockout cells reconstituted with patient variants via knock-in |
| Does RAD50 ATPase activity regulate DNA tethering? | RAD50 ATPase-dead knock-in mutants |
| What is the role of MRN in meiotic recombination? | Germ cell-specific knockout mouse models |
| Can MRN status predict response to PARP inhibitors? | Isogenic knockout cell lines and xenografts |
| How does MRN complex assembly change after DNA damage? | Endogenously tagged knock-in of MRE11, RAD50, NBS1 with fluorescent tags |
How to Study the Mre11 complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screens | Gene essentiality and synthetic lethality | Identify targets in MRN-deficient cancers |
| Cryo-EM | 3D structure of protein complexes | Determine Mre11 complex architecture |
| Comet assay | DNA strand breaks | Assess repair capacity in mutant cells |
| Gamma-H2AX foci | DNA damage response activation | Measure ATM signaling after damage |
| Co-immunoprecipitation | Protein-protein interactions | Map MRN complex interactions |
| Mass spectrometry | Post-translational modifications | Identify UFMylation and phosphorylation sites |
| Yeast genetics | Functional conservation | Study Mre11 complex in S. cerevisiae |
| Fluorescence microscopy | Subcellular localization and dynamics | Track MRN recruitment to damage sites |
CRISPR-Based Genetic Screens
Genome-wide CRISPR knockout screens can identify synthetic lethal interactions with MRN components, revealing potential therapeutic targets. These screens are powerful for uncovering genes that become essential when MRN function is compromised.
Structural Biology and Biochemistry
X-ray crystallography, cryo-EM, and biochemical assays are used to study the architecture and enzymatic activities of the Mre11 complex. Purified recombinant subunits allow detailed dissection of ATPase, nuclease, and DNA-binding functions.
Cell-Based DNA Damage Assays
Comet assays, gamma-H2AX foci, and pulsed-field gel electrophoresis measure DNA damage and repair kinetics in cells with MRN mutations. These assays are used to evaluate radiosensitivity and chemosensitivity.
Proteomics and Interaction Studies
Affinity purification coupled with mass spectrometry identifies MRN interactors and post-translational modifications. Proximity labeling and yeast two-hybrid systems map the interaction network.
How CRISPR Can Be Used to Study GO:0030870 Mre11 complex
Knockout
CRISPR knockout of MRE11, RAD50, or NBS1 generates isogenic cell lines to study loss-of-function phenotypes, including DNA repair defects, radiosensitivity, and cell cycle checkpoint abrogation. These models are valuable for drug sensitivity testing and synthetic lethality screens.
Point Mutation
Knock-in of specific point mutations (e.g., MRE11 H129N, NBS1 657del5) allows precise modeling of patient-derived variants and dissection of domain-specific functions. Such models help determine which activities are critical for DNA repair and checkpoint signaling.
Knock-in
Tagged knock-in of MRE11, RAD50, or NBS1 with fluorescent or affinity tags enables real-time imaging and proteomic analysis of the complex in its native context. This approach preserves endogenous regulation and stoichiometry.
Overexpression
Overexpression of wild-type or mutant MRN subunits can reveal dominant-negative effects or gain-of-function phenotypes. It is useful for studying the impact of elevated MRN levels on DNA repair and cancer cell survival.
How EDITGENE Supports Mre11 complex Research
Researchers studying Mre11 complex-related genes often need to determine whether a candidate gene is causally involved in DNA repair, checkpoint signaling, or disease. EDITGENE provides comprehensive CRISPR services to create precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for Mre11 complex research.
Frequently Asked Questions About Mre11 complex
What is the Mre11 complex?
The Mre11 complex (GO:0030870) is a trimeric protein complex with endonuclease activity involved in DNA repair, meiotic recombination, and checkpoint signaling, composed of MRE11, RAD50, and NBS1 in humans.
What genes are involved in the Mre11 complex?
The core genes are MRE11, RAD50, and NBS1 (NBN) in humans, and MRE11, RAD50, and XRS2 in yeast.
What is the function of the MRN complex?
The MRN complex senses DNA double-strand breaks, processes DNA ends, and activates the ATM checkpoint kinase to coordinate repair.
How is the Mre11 complex linked to cancer?
Mutations in MRE11, RAD50, and NBS1 increase cancer risk and are associated with poor prognosis in some cancers, making them therapeutic targets.
What diseases are caused by Mre11 complex mutations?
Mutations cause Nijmegen breakage syndrome (NBS1), ataxia-telangiectasia-like disorder (MRE11), and RAD50 deficiency, all featuring genomic instability.
What is the difference between MRN and MRX?
MRN is the human complex (MRE11-RAD50-NBS1), while MRX is the yeast complex (Mre11-Rad50-Xrs2); they are orthologous.
How can I study the Mre11 complex using CRISPR?
CRISPR knockout, point mutation knock-in, and tagged knock-in can model loss-of-function, patient variants, and real-time dynamics.
What are the clinical implications of MRN complex alterations?
They predict response to DNA-damaging therapies and PARP inhibitors, and guide precision oncology.
What is the role of MRE11 UFMylation?
UFMylation of MRE11 promotes ATM activation, linking ubiquitin-like modification to DNA damage signaling.
How does the Mre11 complex change conformation?
ATP binding and hydrolysis induce dynamic conformational changes that regulate DNA tethering and nuclease activities.
Conclusion
The Mre11 complex (GO:0030870) is a master regulator of DNA double-strand break repair and checkpoint signaling, with critical roles in genome stability and human disease. Its dynamic structure and multiple enzymatic activities make it a fascinating subject for basic research and a promising target for cancer therapy. CRISPR-based models are indispensable for dissecting its functions and translating findings into clinical applications.
References
- 1. Assenmacher N et al.. 2004. MRE11/RAD50/NBS1: complex activities.. Chromosoma 113(4):157-66 PMID: 15309560
- 2. Reginato G et al.. 2020. The MRE11 complex: A versatile toolkit for the repair of broken DNA.. DNA Repair (Amst) 91-92:102869 PMID: 32480356
- 3. Bian L et al.. 2019. MRE11-RAD50-NBS1 complex alterations and DNA damage response: implications for cancer treatment.. Mol Cancer 18(1):169 PMID: 31767017
- 4. Situ Y et al.. 2019. MRN (MRE11-RAD50-NBS1) Complex in Human Cancer and Prognostic Implications in Colorectal Cancer.. Int J Mol Sci 20(4) PMID: 30769804
- 5. Beikzadeh M et al.. 2021. The dynamic nature of the Mre11-Rad50 DNA break repair complex.. Prog Biophys Mol Biol 163:14-22 PMID: 33121960
- 6. Hohl M et al.. 2025. Structure guided functional analysis of the S. cerevisiae Mre11 complex.. Nat Commun 16(1):7469 PMID: 40796731
- 7. Rahman S et al.. 2020. A Survey of Reported Disease-Related Mutations in the MRE11-RAD50-NBS1 Complex.. Cells 9(7) PMID: 32668560
- 8. Wang Z et al.. 2019. MRE11 UFMylation promotes ATM activation.. Nucleic Acids Res 47(8):4124-4135 PMID: 30783677
